40 results on '"O'Reilly S"'
Search Results
2. 178P Awareness of modifiable lifestyle risk factors and acceptability of secondary risk reduction services amongst Irish breast cancer survivors and oncology clinicians
3. 1292P A review of in-hospital end-of-life care (EOLC) for oncology patients during the COVID-19 pandemic
4. 322P Incidence patterns for locally advanced operable breast cancer by receptor status: SEER 2010-2021
5. 1500P Caring for carers: The impact of death & dying on doctors-in-training in an Irish tertiary referral hospital
6. 1493P An evaluation of the psychological impact of early phase clinical trials in cancer patients
7. 1629P SARS-Cov-2 and Cancer Trials Ireland: Impact, resolution, legacy
8. 2059P The impact of a dental oncology clinic for patients (pts) prescribed bone-modifying agents (BMA) in a cancer centre
9. 1597P Improving in-hospital end-of-life care (EOLC) for oncology patients in a tertiary cancer centre
10. 1763P The challenge for Cancer Trials Ireland (CTI) to sponsor NCI and non-EU sponsored trials in the EU
11. 1730P Dealing with digital paralysis: Surviving a cyberattack in a cancer centre
12. 1726P Optimizing oncology drug spending in a cancer centre in Ireland
13. 123P The prognostic role of lymphocyte count for treatment response in immune checkpoint inhibitor therapy
14. 1751P Lessons from a pandemic: An audit of acute medical oncology admissions during SARS-CoV-2 outbreak
15. 1218P Real world outcome and toxicity of adjuvant chemotherapy in non-small cell lung cancer
16. Feasibility and impact of prospective DPYD screening in the Irish population
17. The impact of the 21 gene recurrence score (RS) on chemotherapy (CHemoRx) prescribing in hormone receptor (HR) positive, lymph node positive (LN+) early-stage breast cancer (BC) in Ireland: A national, multi-centre, prospective study (CTRIAL-IE 15-34)
18. Radiation myositis
19. Oncotype DX score, menopausal status and body mass index
20. Do oncology patients understand clinical trials? A nationwide study by Cancer Trials Ireland
21. Decisions and supports around clinical trial participation: A national study by Cancer Trials Ireland
22. 648P - Feasibility and impact of prospective DPYD screening in the Irish population
23. Malnutrition in 822 Irish cancer patients undergoing chemotherapy: prevalence and impact on quality of life and survival
24. A multi-center, randomized, double-blind phase II trial of FOLFIRI + regorafenib or placebo for patients with metastatic colorectal cancer who failed one prior line of oxaliplatin-containing therapy
25. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as predictive biomarkers of pathologic complete response (pCR) in neoadjuvant breast cancer: an Irish Clinical Oncology Group study (ICORG 16-20)
26. 208P - The impact of the 21 gene recurrence score (RS) on chemotherapy (CHemoRx) prescribing in hormone receptor (HR) positive, lymph node positive (LN+) early-stage breast cancer (BC) in Ireland: A national, multi-centre, prospective study (CTRIAL-IE 15-34)
27. 1465P_PR - Do oncology patients understand clinical trials? A nationwide study by Cancer Trials Ireland
28. 1470P - Decisions and supports around clinical trial participation: A national study by Cancer Trials Ireland
29. 193P - Oncotype DX score, menopausal status and body mass index
30. 1538P - Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as predictive biomarkers of pathologic complete response (pCR) in neoadjuvant breast cancer: an Irish Clinical Oncology Group study (ICORG 16-20)
31. 1447P - Malnutrition in 822 Irish cancer patients undergoing chemotherapy: prevalence and impact on quality of life and survival
32. 464PD - A multi-center, randomized, double-blind phase II trial of FOLFIRI + regorafenib or placebo for patients with metastatic colorectal cancer who failed one prior line of oxaliplatin-containing therapy
33. Predictive and Prognostic Roles of Body Mass Index (BMI) in Docetaxel(D)-Treated Castrate-Resistant Prostate Cancer (CRPC)
34. Utility of Magnetic Resonance Imaging Following Long-Course Pre-Operative Chemo-Radiotherapy for Locally Advanced Rectal Cancer
35. Unilateral nail changes secondary to adriamycin: the protective effect of brachial plexopathy
36. A phase I–II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer
37. High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: A phase II and pharmacodynamic study
38. A phase I and pharmacologic study of DMP 840 administered by 24-hour infusion
39. Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: Natural history of relapse after initial complete response and prognostic variables defining outcome after relapse
40. Hereditary nonpolyposis colorectal cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.